Venus Remedies Reports Strong Financial Performance in Q1 FY25, Receives 'Hold' Rating

Aug 14 2024 10:34 AM IST
share
Share Via
Venus Remedies, a microcap pharmaceutical company, has reported a positive financial performance for the quarter ending March 2024. With a score of 9 out of 10, the company's Profit Before Tax (PBT) and Net Sales have shown significant growth. The company's stock has been given a 'Hold' call by MarketsMojo.

Venus Remedies, a microcap pharmaceutical company, has recently announced its financial results for the quarter ending March 2024. The company’s stock has been given a ‘Hold’ call by MarketsMOJO.

According to the financial report, Venus Remedies has shown a positive performance in the quarter, with a score of 9 out of 10. This is a slight decrease from the previous quarter’s score of 10, but still reflects a strong financial standing.


One of the key factors contributing to this positive performance is the company’s Profit Before Tax (PBT) less Other Income, which has grown by 88.53% year on year to reach Rs 5.26 crore. This indicates a very positive trend in the near term for PBT.


Another positive aspect of the financial report is the company’s Net Sales, which have grown by 21.13% year on year to reach Rs 303.77 crore in the last six months. This shows a positive trend in the near term for sales.


Furthermore, Venus Remedies has also shown improvement in its short term liquidity, with Cash and Cash Equivalents reaching a high of Rs 68.10 crore in the last six half yearly periods.


Overall, the financial results for the quarter ending March 2024 reflect a strong and positive performance for Venus Remedies. With a ‘Hold’ call from MarketsMOJO, the company’s stock is expected to maintain its stability in the near future.


{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News